|
NOVA scienceNOW: Stem Cells Breakthrough
|
|
Program Overview
|
|
Scientists discuss how they transformed fully mature skin cells into
the equivalent of an embryonic stem cell.
This NOVA scienceNOW segment:
-
describes sickle-cell anemia, a blood disease caused by a single
faulty gene. Though it was the first genetic disease identified,
still no cure exists.
-
reports on a new potential treatment for sickle-cell anemia
involving pluripotent embryonic stem cells—cells that can
be turned into any cell type in the body.
-
details the method scientists used to identify the four genes
responsible for transforming fully developed skin cells into
pluripotent embryonic stem cells. These new cells are called
induced Pluripotent Stem (iPS) cells.
-
describes the technique scientists first used to make iPS cells
from the skin cells of adult mice: Scientists initiated the
process by attaching the four key genes to a virus, which
inserted them into the skin cells. The four genes "erased" all
skin functions and turned the skin cells into iPS cells.
-
points out that iPS and embryonic stem cells look the same and
seem to function identically.
-
mentions that researchers have used iPS cells to cure
sickle-cell disease in trials run on mice.
-
reports that in less than one year after the discovery, other
scientists transformed human skin cells into iPS stem cells.
-
points out challenges that must be overcome before iPS cells can
help patients like those with sickle cell anemia. For example,
one of the four genes can mutate a patient's DNA and cause
cancer.
-
explains that scientists are uncertain whether iPS cells can
dependably grow into all cell types. Until this is confirmed,
embryonic stem cells remain the gold standard of stem cells.
Taping Rights: Can be used up to one year after the program
is taped off the air.
|
Stem Cells Breakthrough
Find an abbreviated version of this NOVA scienceNOW
video segment
(5m 16s) on Teachers' Domain.
|
|